CRO Industry In The Clinical Trial

The sky high prices of the clinical trial in the past year raised the curtain for the new trends in the clinical trial. To cut down the raising clinical trial costs, the pharmaceutical companies entered the new approach contract research organizations. Pharmaceutical companies were able to play the key role in reshaping the new clinical trial.  The services offered by the contract research organizations initiated with clinical research activities like research and development. Today, the services offered by these contract research organizations expand to wide ranges which include preclinical evaluations, study design, clinical trial planning and management, independent data safety monitoring, bio-statistical analysis and many more. 

With the big pharmaceutical companies out sourcing the clinical research activities, the CRO markets experienced a quick growth in the short span.

Reverse The Discouraging Trends In Adaptive Clinical Trials

Not all the clinical trials that are conducted to bring the new improved medication in to the market end up in the positive note. Most of the studies show up failures and the result is huge waste of time money and valuable man power. Why is this wastage happening? It is because lack of proper research? Is it because of the lack of co-ordination between the patients and the investigators? I say, it  is because of the rigid clinical trial process that are in place. The protocol of the clinical trial should be flexible and should be adaptive so that the researcher can make the necessary up gradation to bring in clinical trial to desired positive zone.

Foreign Companies Have Become Massive Testing Grounds For Clinical Trials

US is the hub of clinical trials conducted in the medical world. This statement stands true no longer true. Most of the clinical today are conducted in the foreign nation like Russia, China, Brazil, Poland, Uganda, and Romania. Economic feasibility is the main reason behind conducting the clinical trials in faraway locations in spite of the sponsor, the pharmaceutical company having its base in US. The clinical trial industry turned into big business worth $30 billion in these faraway nations.

When these clinical trials are conducted in foreign nations, few common security questions that are whether these clinical trials are properly monitored by FDA regulations? Do the volunteers have the clear picture about the informed consent? Are they actually aware that they are participation in the clinical trials? If clinical trial is able to give the right answer to all these queries, then globalization of  the clinical trials turn to be very economical.

Does Prostate Cancer Clinical Trials Benefit You?

No medication for the cancer treatments would be available in today’s market in the absence of the clinical trials. Participation in the clinical trials should benefit you because of few factors like accessibility to the medication, quality of care, high standard of clinical practice and close monitoring of the clinical staff.

Apart from the huge benefits offered by the cancer clinical trials, they suffer from few drawbacks too.  no cancer clinical trial is risk free. The participant of the clinical trial should be notified about the possible health risks in the clinical trial before he participates.

Good news to the sufferers of advanced Melanoma

It is time for the celebration for the patients suffering from advanced melanoma. The new drugs in the clinical trials are showing the promising results in increasing the life span of patients suffering from advanced Melanoma.

The recent clinical trials conducted to conclude the efficiency of the drug showed the positive results. The active group of the clinical trial showed an increase in the lifespan when compared to the controlled group. The risk of losing the life was reduced to 63 percent. The drug showed the positive results by working in two ways, one by combating cancer by attacking specific genetic mutation that accelerates the tumor growth. The second way is by unleashing body’s immune system to fight the diseases.

Paper Less Clinical Trials Will Soon Become The Norm.

Everything in the world today goes paperless; to your surprise the paper work carried to conduct the clinical trials in world of technology produced 100,000 pages of documents. It is very important to take the effective measures to reduce the paper work and increase the efficiency of the clinical trials. Integrating clinical trials with the technology will reduce the time to the market.

Moving to paperless clinical trials involve some challenges too. For the paperless clinical trials to be successful they have to be secure, stable, scalable and should be supported both internally and externally.  To bring the paperless clinical trials into reality, content management system should have industry-wide agreement on the technologies, standards and protocols and business processes. Contributing to the paperless clinical trials, solutions should integrate with other application and seamlessly integrate the data from different sources into common, accessible formats in order to improve the data exchange and foster the collaboration. Paper less clinical trials stand as norm when they abide the regulations of FDA apart from increasing the efficiency of the clinical trials.

Clinical Trials Are In Process To Bring The New Drug To Treat Fanconi Anemia

Fanconi Anemia is a blood disease that leads to bone marrow failure. It affects all systems of the body and prevents the diseased from reaching the adulthood.  The only long term cure available for Fanconi Anemia patients is bone bone marrow transplant from an exact-match sibling. The present treatment is associated with many risks. Clinical grade material will be prepared based on the Molecular and Cellular Therapeutics of University of Minnesota. The clinical trial is being directed by the experienced physicians in the world for the treatment of FA. The trial can be planned with low number of patients to complete the trail quickly at low cost.

The patient will be initially checked in the health center after which the patient’s bone marrow sample is taken. This will be followed up under the doctor’s observation.  Treated bone marrow cells are returned to the patient. SB- therurapic is delivered into patient’s bone marrow steam cells.